Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 27, 2023

BUY
$0.58 - $1.47 $14,154 - $35,875
24,405 New
24,405 $14,000
Q2 2023

Jul 18, 2023

BUY
$1.11 - $1.74 $37,914 - $59,433
34,157 Added 278.81%
46,408 $60,000
Q1 2023

Apr 13, 2023

BUY
$1.66 - $3.67 $4,750 - $10,503
2,862 Added 30.48%
12,251 $21,000
Q4 2022

Jan 23, 2023

SELL
$2.77 - $5.07 $2,260 - $4,137
-816 Reduced 8.0%
9,389 $29.5 Million
Q3 2022

Oct 26, 2022

BUY
$4.27 - $6.39 $10,440 - $15,623
2,445 Added 31.51%
10,205 $50,000
Q2 2022

Jul 25, 2022

SELL
$3.28 - $6.21 $232,699 - $440,568
-70,945 Reduced 90.14%
7,760 $32,000
Q1 2022

May 02, 2022

SELL
$5.23 - $7.82 $99,751 - $149,150
-19,073 Reduced 19.51%
78,705 $457,000
Q4 2021

Jan 28, 2022

BUY
$7.29 - $10.97 $712,801 - $1.07 Million
97,778 New
97,778 $733,000

Others Institutions Holding SGMO

About SANGAMO THERAPEUTICS, INC


  • Ticker SGMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 156,552,992
  • Market Cap $193M
  • Description
  • Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...
More about SGMO
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.